November 23-24 2022 ENS Lyon, France
News Twitter
8h00
Registration & welcome coffee
8h45
Welcome Address
9h00
Opening lectures
Tim Walsh
Professor of Medical Microbiology
Oxford University - UK
10h00
Coffee Break - Exhibition Hall - B2B Meetings
10h30
Track 1 : Alternative to antibiotics and current antiviral
Session 1
Sofia Côrte Real
Scientific advisor
TechnoPhage - Portugal
Sanja Selak
Managing director and CSO
ORIGIMM Biotechnology - Austria
Vincent Libis
Research Group Leader
INSERM - France
Track 2 : Immunotherapies
Session 1
Jean Chastre
PU-PH
APHP - France
Antoine Alam
Antiviral Research Head
Evotec, France
Alexis Rideau
CEO
Deinove, France
12h00
Lunch - Exhibition Hall - B2B Meetings 2 slots
13h00
Poster Presentation - Exhibition Hall - B2B Meetings 3 slots
14h00
Track 1 : Alternative to antibiotics and current antiviral
Session 2
Ajay Mistry
CEO
Oppilotech - UK
Jon Stokes
Assistant Professor
Stokes Laboratory / McMaster University - Canada
Track 2 : Immunotherapies
Session 2
Anne-Claire Lukaszewicz
Head of Department
Hospices Civils de Lyon - France
Hasan Jafri
Chief Medical Officer
Aridis Pharmaceuticals - USA
15h30
Coffe Break - Exhibition Hall - B2B Meetings 3 slots
16h00
Track 1 : Alternative to antibiotics and current antiviral
Session 3
Breakthrough innovation Session
17h30
End of Day 1
8h30
Welcome coffee
9h00
Opening lectures
10h00
Coffe Break - Exhibition Hall - B2B Meetings
10h30
Track 4 : vaccine
Session 1
Anne-Sophie Beignon
Researcher
Inserm, CEA, IMVA-HB/IDMIT - France
Isabelle Dimier-Poisson
CSO
LoValTech - France
Patrick Barillot
CEO
LoValTech - France
Track 5 : Biomarker
Session 1
12h00
Lunch - Exhibition Hall - B2B Meetings 2 slots
13h00
Poster Presentation - Exhibition Hall - B2B Meetings 3 slots
14h00
Track 4 : Vaccine
Session 2
Sylvain Baize
PI
Pasteur Institute - France
15h40
Closing lecture
16h10
Best Poster - Annoucemment of next year edition
16h30
End of congress
